Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine safety and efficacy of a new gel formulation of
Esmolol hydrochloride (Galnobax®) for the treatment of Diabetic Foot Ulcer (DFU). The study
will compare number and types of adverse events occured, rates of wound closure and
percentage of wounds closed in Galnobax treated groups versus placebo group.